Institutions / 5AM Venture Management, LLC
5AM Venture Management, LLC
CIK 1799883 · Institution · as of Dec 31, 2025
Portfolio value
$318.10M
Positions
21
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Entrada Therapeutics, Inc.TRDA | $41.70M | 13.1% |
| Camp4 Therapeutics Corp | $35.98M | 11.3% |
| Tyra Biosciences, Inc. | $27.06M | 8.5% |
| Viridian Therapeutics, Inc. | $22.92M | 7.2% |
| Pharvaris N.V. | $22.13M | 7.0% |
| Erasca, Inc.ERAS | $20.11M | 6.3% |
| EyePoint, Inc. | $19.18M | 6.0% |
| Maplight Therapeutics IncMPLT | $16.69M | 5.2% |
| Centessa Pharmaceuticals PLC | $14.53M | 4.6% |
| Celldex Therapeutics, Inc. | $13.51M | 4.2% |
| Tectonic Therapeutic, Inc.TECX | $12.65M | 4.0% |
| Enliven Therapeutics, Inc.ELVN | $11.90M | 3.7% |
| Artiva Biotherapeutics, Inc. | $10.10M | 3.2% |
| Surrozen, Inc./DESRZN | $8.76M | 2.8% |
| Biohaven Ltd. | $8.34M | 2.6% |
| Protara Therapeutics, Inc. | $7.30M | 2.3% |
| Gh Research PLC | $7.27M | 2.3% |
| Skye Bioscience, Inc.SKYE | $7.26M | 2.3% |
| Zentalis Pharmaceuticals, Inc.ZNTL | $5.33M | 1.7% |
| Silence Therapeutics plcSLN | $2.90M | 0.9% |
| Rallybio Corp | $2.49M | 0.8% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.